Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21
Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination wi...
Saved in:
Published in: | Frontiers in immunology Vol. 10; p. 879 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
24-04-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells
using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction.
K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4-5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells.
The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation.
Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion. |
---|---|
AbstractList | Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction.Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4–5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells.Results: The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation.Conclusion: Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion. Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction. K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4-5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells. The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation. Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion. Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction. Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations only once at the beginning of the culture. NK cells were expanded for 4–5 weeks, and the purity, expansion rate, phenotype and function (cytotoxicity, antibody-dependent cell-mediated cytotoxicity (ADCC), cytokine production, CD107a degranulation) of these expanded NK cells were compared to those generated by using K562 feeder cells. Results: The culture of NK cells with K562-OX40L cells in combination with the transient exposure to IL-21 highly enhanced NK cell expansion to approximately 2,000-fold after 4 weeks of culture, compared to a 303-fold expansion using the conventional K562 cells. Mechanistically, the OX40-OX40L axis between the feeder cells and NK cells as well as the homotypic interaction between NK cells through the OX40-OX40L axis were both necessary for NK cell expansion. The short exposure of NK cells to IL-21 had a synergistic effect with OX40 signaling for NK cell expansion. Apart from their enhanced expansion, NK cells grown with K562-OX40L feeder cells were similar to those grown with conventional K562 cells in regard to the surface expression of various receptors, cytotoxicity, ADCC, cytokine secretion, and CD107 degranulation. Conclusion: Our data suggest that OX40 ligand is a potent co-stimulant for the robust expansion of human NK cells and the homotypic NK cell interactions through the OX40-OX40L axis is a mechanism of NK cell expansion. |
Author | Kweon, SoonHo Yu, HongBi Lee, Jaemin Kim, Jinho Ali, Alaa Kassim Lee, Seung-Hwan Cho, Duck Doh, Junsang Kim, Seokho Phan, Minh-Trang Thi Kim, Sang-Ki Chun, Sejong |
AuthorAffiliation | 6 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada 10 Stem Cell and Regenerative Medicine Institute, Samsung Medical Center , Seoul , South Korea 3 Department of Laboratory Medicine, Chonnam National University , GwangJu , South Korea 1 School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH , Pohang , South Korea 9 Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea 5 Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology , Daejeon , South Korea 4 Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University , Seoul , South Korea 7 Laboratory Animal Science, Department of Companion, Kongju National University , Yesan , South Korea 8 Department of Materials Science and Engineering, Seoul National University , Seoul , South Korea 2 Department of Mechanical Engineering, POSTE |
AuthorAffiliation_xml | – name: 8 Department of Materials Science and Engineering, Seoul National University , Seoul , South Korea – name: 10 Stem Cell and Regenerative Medicine Institute, Samsung Medical Center , Seoul , South Korea – name: 1 School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH , Pohang , South Korea – name: 4 Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University , Seoul , South Korea – name: 9 Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea – name: 7 Laboratory Animal Science, Department of Companion, Kongju National University , Yesan , South Korea – name: 2 Department of Mechanical Engineering, POSTECH , Pohang , South Korea – name: 6 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada – name: 3 Department of Laboratory Medicine, Chonnam National University , GwangJu , South Korea – name: 5 Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology , Daejeon , South Korea – name: 11 Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University , Seoul , South Korea |
Author_xml | – sequence: 1 givenname: SoonHo surname: Kweon fullname: Kweon, SoonHo organization: School of Interdisciplinary Bioscience and Bioengineering (I-Bio), POSTECH, Pohang, South Korea – sequence: 2 givenname: Minh-Trang Thi surname: Phan fullname: Phan, Minh-Trang Thi organization: Department of Mechanical Engineering, POSTECH, Pohang, South Korea – sequence: 3 givenname: Sejong surname: Chun fullname: Chun, Sejong organization: Department of Laboratory Medicine, Chonnam National University, GwangJu, South Korea – sequence: 4 givenname: HongBi surname: Yu fullname: Yu, HongBi organization: Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea – sequence: 5 givenname: Jinho surname: Kim fullname: Kim, Jinho organization: Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea – sequence: 6 givenname: Seokho surname: Kim fullname: Kim, Seokho organization: Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea – sequence: 7 givenname: Jaemin surname: Lee fullname: Lee, Jaemin organization: Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea – sequence: 8 givenname: Alaa Kassim surname: Ali fullname: Ali, Alaa Kassim organization: Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada – sequence: 9 givenname: Seung-Hwan surname: Lee fullname: Lee, Seung-Hwan organization: Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada – sequence: 10 givenname: Sang-Ki surname: Kim fullname: Kim, Sang-Ki organization: Laboratory Animal Science, Department of Companion, Kongju National University, Yesan, South Korea – sequence: 11 givenname: Junsang surname: Doh fullname: Doh, Junsang organization: Department of Materials Science and Engineering, Seoul National University, Seoul, South Korea – sequence: 12 givenname: Duck surname: Cho fullname: Cho, Duck organization: Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31105701$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUtr3DAUhUVJaR7NvquiZTee6v3YFMqQJkOGZtEGuhOyfTVxsKWpZIf239fzaEgEF4mjcz9ddM7RSUwREPpAyYJzYz-HbhimBSPULggx2r5BZ1QpUXHGxMmL8ym6LOWRzEtYzrl8h045pURqQs-Qu_qz9bF0KeIU8M00-Ii_3-Il9H3B96WLG3wrFTsKszlD2at3vwTB627jY4t39eMh5XFnSGXKgMeEV-uK0ffobfB9gcvjfoHuv139XN5U67vr1fLrumqEYmPVeh2ssVQrCQoU40FCUMDBeCmsrAljSgQtSSOA0CZYYiCAZjI0hFMj-AVaHbht8o9um7vB578u-c7thZQ3zuexa3pwtSQzWdWSmVYYXhtBTGNb4JpboaGdWV8OrO1UD9A2EMfs-1fQ1zexe3Cb9OSUsNQSNgM-HQE5_Z6gjG7oSjP_oI-QpuIY44xozZSereRgbXIqJUN4foYSt4vZ7WN2u5jdPua55ePL8Z4b_ofK_wFSUqNE |
CitedBy_id | crossref_primary_10_1007_s00109_021_02120_z crossref_primary_10_1016_j_jcyt_2023_07_002 crossref_primary_10_1016_j_phrs_2020_104691 crossref_primary_10_3389_fimmu_2022_1044946 crossref_primary_10_1038_s41573_019_0052_1 crossref_primary_10_3390_cancers12030706 crossref_primary_10_1016_j_critrevonc_2021_103261 crossref_primary_10_3389_fimmu_2020_01851 crossref_primary_10_1016_j_omtm_2020_06_014 crossref_primary_10_3390_cells9040811 crossref_primary_10_1016_j_biopha_2023_115907 crossref_primary_10_1007_s00262_021_02982_9 crossref_primary_10_1021_acssensors_0c02138 crossref_primary_10_3390_cells13050451 crossref_primary_10_1002_mco2_422 crossref_primary_10_1016_j_mam_2020_100870 crossref_primary_10_1038_s41573_022_00413_7 crossref_primary_10_3389_fimmu_2022_841107 crossref_primary_10_3389_fimmu_2022_859177 crossref_primary_10_3389_fonc_2021_632540 crossref_primary_10_12677_ACM_2023_134719 crossref_primary_10_1186_s12943_022_01561_5 crossref_primary_10_1186_s40164_023_00431_0 crossref_primary_10_1016_j_jconrel_2022_01_049 crossref_primary_10_1007_s10404_022_02600_9 crossref_primary_10_1128_jvi_00372_22 crossref_primary_10_3389_fonc_2022_1062765 crossref_primary_10_2174_1574888X17666220107101722 crossref_primary_10_1002_cdt3_40 crossref_primary_10_1007_s00262_022_03322_1 crossref_primary_10_1016_j_omtm_2021_02_023 crossref_primary_10_3343_alm_2022_42_6_638 crossref_primary_10_3390_cancers15061743 crossref_primary_10_3389_fimmu_2022_953849 crossref_primary_10_3390_cancers13164129 crossref_primary_10_1016_j_drudis_2020_11_028 crossref_primary_10_1016_j_jcyt_2020_12_002 crossref_primary_10_1038_s41598_024_56297_7 crossref_primary_10_1038_s41423_021_00808_3 crossref_primary_10_3390_cancers13030577 crossref_primary_10_1186_s13045_019_0801_y crossref_primary_10_3390_vaccines11010165 crossref_primary_10_1016_j_cyto_2021_155599 crossref_primary_10_1038_s41598_023_36200_6 crossref_primary_10_15789_1563_0625_MMS_1976 crossref_primary_10_3389_fonc_2023_1117781 crossref_primary_10_3390_jcm8101702 crossref_primary_10_1016_j_intimp_2022_109041 crossref_primary_10_3390_biomedicines9060662 crossref_primary_10_3389_fimmu_2021_648580 crossref_primary_10_3389_fimmu_2021_680611 crossref_primary_10_1016_j_tibtech_2023_03_018 crossref_primary_10_3390_cells10050967 crossref_primary_10_4049_jimmunol_2200422 crossref_primary_10_1002_adbi_202000195 crossref_primary_10_1007_s00432_023_05148_5 crossref_primary_10_3390_ijms23169426 crossref_primary_10_1111_imr_12793 |
Cites_doi | 10.3343/kjlm.2009.29.2.89 10.1016/j.jcyt.2014.04.008 10.4049/jimmunol.168.10.4897 10.1146/annurev-immunol-030409-101243 10.1074/jbc.M110.137976 10.1182/blood-2004-12-4797 10.4049/jimmunol.176.10.5975 10.1158/1078-0432.ccr-12-1243 10.1073/pnas.0306567101 10.5045/br.2014.49.3.154 10.4049/jimmunol.167.2.875 10.1158/2326-6066.cir-17-0212 10.1158/0008-5472.can-12-2893 10.1007/978-1-4939-3684-7_14 10.1038/s41598-018-20656-y 10.1111/j.1600-065X.2009.00766.x 10.1016/j.jhep.2017.10.021 10.1080/2162402x.2016.1219007 10.1371/journal.pone.0030264 10.4049/jimmunol.150.5.1705 10.1615/CritRevImmunol.v29.i3.10 |
ContentType | Journal Article |
Copyright | Copyright © 2019 Kweon, Phan, Chun, Yu, Kim, Kim, Lee, Ali, Lee, Kim, Doh and Cho. 2019 Kweon, Phan, Chun, Yu, Kim, Kim, Lee, Ali, Lee, Kim, Doh and Cho |
Copyright_xml | – notice: Copyright © 2019 Kweon, Phan, Chun, Yu, Kim, Kim, Lee, Ali, Lee, Kim, Doh and Cho. 2019 Kweon, Phan, Chun, Yu, Kim, Kim, Lee, Ali, Lee, Kim, Doh and Cho |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fimmu.2019.00879 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
EndPage | 879 |
ExternalDocumentID | oai_doaj_org_article_b506e36b528d483b8408c9de373947ed 10_3389_fimmu_2019_00879 31105701 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: 2015R1D1A1A09058740 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EBS EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ KQ8 M48 M~E NPM OK1 PGMZT RIG RNS RPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c462t-da7f9891765e6e623f5ef6e3e8a5495b02264f750c4e01cf908efe725fc031843 |
IEDL.DBID | RPM |
ISSN | 1664-3224 |
IngestDate | Tue Oct 22 15:12:01 EDT 2024 Tue Sep 17 21:25:59 EDT 2024 Sat Oct 26 01:41:31 EDT 2024 Thu Sep 26 18:24:43 EDT 2024 Sat Sep 28 08:28:31 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | natural killer cells OX40 ligand K562 IL-21 expansion |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-da7f9891765e6e623f5ef6e3e8a5495b02264f750c4e01cf908efe725fc031843 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Eleanor Riley, University of Edinburgh, United Kingdom These authors have contributed equally to this work Reviewed by: Volker Huppert, Glycostem, Netherlands; Jacki Kornbluth, Saint Louis University, United States This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491902/ |
PMID | 31105701 |
PQID | 2232077267 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b506e36b528d483b8408c9de373947ed pubmedcentral_primary_oai_pubmedcentral_nih_gov_6491902 proquest_miscellaneous_2232077267 crossref_primary_10_3389_fimmu_2019_00879 pubmed_primary_31105701 |
PublicationCentury | 2000 |
PublicationDate | 2019-04-24 |
PublicationDateYYYYMMDD | 2019-04-24 |
PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-24 day: 24 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2019 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Lim (B13) 2014; 16 Granzin (B14) 2016; 5 Robertson (B2) 1993; 150 Croft (B18) 2010; 28 Croft (B19) 2009; 229 Nuebling (B8) 2018; 6 Pollmann (B15) 2018; 68 Baba (B20) 2001; 167 Kim (B12) 2010; 285 Soroosh (B21) 2006; 176 Phan (B9) 2016; 1441 Cho (B1) 2009; 29 Turaj (B7) 2018; 8 Imai (B4) 2005; 106 Park (B10) 2012; 32 Redmond (B22) 2009; 29 Lim (B11) 2013; 73 Bukczynski (B17) 2004; 101 Wen (B16) 2002; 168 Liu (B6) 2013; 19 Bae (B3) 2014; 49 Denman (B5) 2012; 7 |
References_xml | – volume: 29 start-page: 89 year: 2009 ident: B1 article-title: Expansion and activation of natural killer cells for cancer immunotherapy publication-title: Korean J Lab Med doi: 10.3343/kjlm.2009.29.2.89 contributor: fullname: Cho – volume: 32 start-page: 839 year: 2012 ident: B10 article-title: Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells publication-title: Anticancer Res contributor: fullname: Park – volume: 16 start-page: 1419 year: 2014 ident: B13 article-title: Effect of exposure to interleukin-21 at various time points on human natural killer cell culture publication-title: Cytotherapy doi: 10.1016/j.jcyt.2014.04.008 contributor: fullname: Lim – volume: 168 start-page: 4897 year: 2002 ident: B16 article-title: 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function publication-title: J Immunol doi: 10.4049/jimmunol.168.10.4897 contributor: fullname: Wen – volume: 28 start-page: 57 year: 2010 ident: B18 article-title: Control of immunity by the TNFR-related molecule OX40 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-030409-101243 contributor: fullname: Croft – volume: 285 start-page: 41755 year: 2010 ident: B12 article-title: Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2 publication-title: J Biol Chem doi: 10.1074/jbc.M110.137976 contributor: fullname: Kim – volume: 106 start-page: 376 year: 2005 ident: B4 article-title: Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells publication-title: Blood doi: 10.1182/blood-2004-12-4797 contributor: fullname: Imai – volume: 176 start-page: 5975 year: 2006 ident: B21 article-title: OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity publication-title: J Immunol doi: 10.4049/jimmunol.176.10.5975 contributor: fullname: Soroosh – volume: 19 start-page: 2132 year: 2013 ident: B6 article-title: Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy publication-title: Clin Cancer Res doi: 10.1158/1078-0432.ccr-12-1243 contributor: fullname: Liu – volume: 101 start-page: 1291 year: 2004 ident: B17 article-title: Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0306567101 contributor: fullname: Bukczynski – volume: 49 start-page: 154 year: 2014 ident: B3 article-title: Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line publication-title: Blood Res doi: 10.5045/br.2014.49.3.154 contributor: fullname: Bae – volume: 167 start-page: 875 year: 2001 ident: B20 article-title: Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand publication-title: J Immunol doi: 10.4049/jimmunol.167.2.875 contributor: fullname: Baba – volume: 6 start-page: 209 year: 2018 ident: B8 article-title: The immune checkpoint modulator OX40 and its ligand OX40L in NK-cell immunosurveillance and acute myeloid leukemia publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.cir-17-0212 contributor: fullname: Nuebling – volume: 73 start-page: 2598 year: 2013 ident: B11 article-title: Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy publication-title: Cancer Res doi: 10.1158/0008-5472.can-12-2893 contributor: fullname: Lim – volume: 1441 start-page: 167 year: 2016 ident: B9 article-title: Expansion of NK cells using genetically engineered K562 feeder cells publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-3684-7_14 contributor: fullname: Phan – volume: 8 start-page: 2278 year: 2018 ident: B7 article-title: Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking publication-title: Sci Rep doi: 10.1038/s41598-018-20656-y contributor: fullname: Turaj – volume: 229 start-page: 173 year: 2009 ident: B19 article-title: The significance of OX40 and OX40L to T-cell biology and immune disease publication-title: Immunol Rev doi: 10.1111/j.1600-065X.2009.00766.x contributor: fullname: Croft – volume: 68 start-page: 421 year: 2018 ident: B15 article-title: Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis publication-title: J Hepatol doi: 10.1016/j.jhep.2017.10.021 contributor: fullname: Pollmann – volume: 5 start-page: e1219007 year: 2016 ident: B14 article-title: Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma publication-title: Oncoimmunology doi: 10.1080/2162402x.2016.1219007 contributor: fullname: Granzin – volume: 7 start-page: e30264 year: 2012 ident: B5 article-title: Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells publication-title: PLoS ONE doi: 10.1371/journal.pone.0030264 contributor: fullname: Denman – volume: 150 start-page: 1705 year: 1993 ident: B2 article-title: Costimulatory signals are required for optimal proliferation of human natural killer cells publication-title: J Immunol doi: 10.4049/jimmunol.150.5.1705 contributor: fullname: Robertson – volume: 29 start-page: 187 year: 2009 ident: B22 article-title: The role of OX40-mediated co-stimulation in T-cell activation and survival publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.v29.i3.10 contributor: fullname: Redmond |
SSID | ssj0000493335 |
Score | 2.5119174 |
Snippet | Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new... Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we... Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 879 |
SubjectTerms | expansion IL-21 Immunology K562 natural killer cells OX40 ligand |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgEhIXxDfhS0biwiGqE48d5whlq6JW5VCQerPieEy3ahPE7krw75lxtqtdhMSFQy6OpVhvMvGb8eSNEG9jW2EbdCiR9tYSwJiy7ckfQ3IWYqgAkXO6R2fN6bn7OGOZnE2rL64Jm-SBJ-D2g1EWtQ2mdhGcDhSQuL6NqBvdQoMxf32V3QqmLifeq7U207kkRWHtfppfX6-4lIv1KR1Xbm3tQ1mu_28c889Sya295_C-uLcmjfL9tNgH4hYOD8WdqY3kr0fCz36ST3PaS45J5rS8PD2WB3h1tZC5JkAeEwFZD9DkXPtKo5_PQcmT-bduiJKvswsi4zxh5LyhXI7y00lZV4_F18PZl4Ojct04oezB1ssydk1qHQVi1qBlIySDiVBE11E4aILiv2cTcYUeUFV9apXDhE1tUs8-DvqJ2BvGAZ8JCdGp3pngiIcBJHChSV3P8tYAaLtUiHc3MPrvkz6Gp7iCIfcZcs-Q-wx5IT4wzpt5rGydB8jefm1v_y97F-LNjZU8eQIfb3QDjquFJ6JTKwoWbFOIp5PVNo_SFfczVlUhmh177qxl984wv8hq2xZaIk318_-x-BfiLsPBp1E1vBR7yx8rfCVuL-LqdX5_fwOF_PIj priority: 102 providerName: Directory of Open Access Journals |
Title | Expansion of Human NK Cells Using K562 Cells Expressing OX40 Ligand and Short Exposure to IL-21 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31105701 https://search.proquest.com/docview/2232077267 https://pubmed.ncbi.nlm.nih.gov/PMC6491902 https://doaj.org/article/b506e36b528d483b8408c9de373947ed |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbdQKGX0nfdR1Chlx6ctS3Jko_tdkNK0rSQFnITljxKNuzaIbsL7b_vjGyHbOmpB19kGYtvNMxDo28Ye99UOVROuBTQtqZSKpVWHvXRBVPKxuUSgHK6R2f69Nx8nhNNjhrvwsSife8WB-1yddAuLmNt5fXKT8c6sen3r7NSVmjHiumETdA3vBOiX_UurxBC9UeSGIBV07BYrbZUxUXUlEYTUajIqb_t0AlmtEaRtP9fnubfBZN3LNDhI_ZwcB35x36Jj9k9aJ-w-30zyd9PmZ3_Qs2m5BfvAo_JeX56zGewXK55rAzgx-iGDAM4OVbA4ui3c5nxk8VF3TacnrNLdMlpQkfZQ77p-JeTtMifsZ-H8x-zo3Ron5B6WRabtKl1qAyGY6WCkkQRFIQSBJgag0LlMrpDG9Bj8BKy3IcqMxBAFyp40nQpnrO9tmvhJeOyMZk3yhlETcogjdOh9kRyLSWUdUjYhxFGe92zZFiMLgh9G9G3hL6N6CfsE-F8O4_4reNAd3NhBylbpzJcaelUYRpphMMw1PiqAaFFJTU0CXs3SsmiPtAhR91Ct11bdHeKDEOGUifsRS-121-NUk-Y3pHnzlp23-AWjJzbw5Z79d9fvmYPCAM6iCrkG7a3udnCWzZZN9v9mAfYj7v4D5PA9Ag |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCbWDsN22fuRPTVglx3c2JZky8ctS5EiaTagHdCbYMlSmyGxiyYBtn8_UraLZtipB19kGRb4iRJJUR8BPlVF4grDTeRwb42EkDIqLOqj8SoTlUmEcxTTnZzk8zP1bUw0ObK_CxOS9q1ZHNTL1UG9uAi5lZcrO-zzxIY_jkeZKHAfS4d7cBf1NY5vOOm_WqOXcy7bQ0l0wYqhX6xWW8rjInJKlRNVKE-owm1XC6bfjwJt__9szX9TJm_sQYePbjn6x_CwMzrZl_b1E7jj6qdwry1D-ecZ6PFvXBMobMYaz0JYn82nbOSWyzULOQVsigZM14CdQ-4stn4_EzGbLc7LumL0nFygMU8dGoo7sk3DjmZRmjyHn4fj09Ek6govRFZk6SaqytwXCh25TLqMQPTS-cxxp0p0J6WJ6fatR1vDChcn1hexct7lqfSW1gjBX8B-3dTuFTBRqdgqaRRKWwgvlMl9aYkeWwiXlX4An3vx68uWX0OjX0Ko6YCaJtR0QG0AXwmf637EjB0amqtz3UlYGxnjSDMjU1UJxQ06sMoWleM5L0TuqgF87NHVqEl0PFLWrtmuNRpKaYzORpYP4GWL9vWv-tkygHxnHuyMZfcNwh_Yuju4X9_6yw9wf3J6PNOzo_n0DTwgedBxVirewv7mauvewd662r4POvAXpjcIqQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYRSAuvB_laSQuHLJ52E6cI3Rb7aqlrLQg7c2KX7tFbVJtWwn-PTNOUm0RJzjk4kwUx5_HnhlPviHkgy1TV2qmIwd7a8S5EFFpQB-1lzm3OuXOYUz35LyYXcjjEdLk7Ep9haR9o-dH9WJ5VM-vQm7lamniPk8sPvsyzHkJ-1gWr6yPD8ht0Nkku-Go_2gNX8aYaA8mwQ0rYz9fLreYy4UElbJAulCWYpXbrh5MvycF6v6_2Zt_pk3e2IfGD_7jCx6S-53xST-1Io_ILVc_JnfacpS_nhA1-glrA4bPaONpCO_T2YQO3WKxpiG3gE7AkOkaQDjk0ELr1wue0On8sqotxev8Cox6FGgw_kg3DT2dRln6lHwfj74NT6KuAENkeJ5tIlsVvpTg0OXC5QimF87njjlZgVspdIJ_4XqwOQx3SWp8mUjnXZEJb3Ct4OwZOayb2r0glFuZGCm0hBHn3HOpC18ZpMnm3OWVH5CPPQRq1fJsKPBPEDkVkFOInArIDchnxGgnhwzZoaG5vlTdKCstEuhprkUmLZdMgyMrTWkdK1jJC2cH5H2PsAKNwmOSqnbNdq3AYMoScDryYkCet4jvXtXPmAEp9ubCXl_278AUCKzdHeQv__nJd-Tu2fFYTU9nk1fkHg4Hnmpl_DU53Fxv3RtysLbbt0ENfgMWCQsp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expansion+of+Human+NK+Cells+Using+K562+Cells+Expressing+OX40+Ligand+and+Short+Exposure+to+IL-21&rft.jtitle=Frontiers+in+immunology&rft.au=Kweon%2C+SoonHo&rft.au=Phan%2C+Minh-Trang+Thi&rft.au=Chun%2C+Sejong&rft.au=Yu%2C+HongBi&rft.date=2019-04-24&rft.eissn=1664-3224&rft.volume=10&rft.spage=879&rft.epage=879&rft_id=info:doi/10.3389%2Ffimmu.2019.00879&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |